| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9362339 | Otolaryngology - Head and Neck Surgery | 2005 | 21 Pages |
Abstract
We conclude that the current FDA (draft) guidelines calling for a study length of 2 weeks for the assessment of drug efficacy for SAR and 4 weeks for the study of drug efficacy in PAR are appropriate and that longer study periods are not likely to add meaningfully to the assessment of drug efficacy.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
John H. MD, PhD, Peter S. MD, Bradley F. MD, G. Michael PhD, Maureen PhD, Suman MD, Darrell MD,